New Issue | Current Medicinal Chemistry; Volume 27 Issue 4

cmc

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth/mini reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

 

Articles from the journal: Current Medicinal Chemistry; Volume 27 Issue 4

For details on the articles, please visit this link: http://www.eurekaselect.com/node/602/current-medicinal-chemistry/issue/27/2698/4/9716

Animated Abstract | Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps

Extend the scope and visibility of your research by creating an animated abstract.

 

Bentham Science has collaborated with Focus Medica, one of the world’s largest publishers of expert animated atlases and videos in medicine and science.

An animated abstract will help summarise the essential discoveries/ key findings of your published research or review article. Each professionally produced full-coloured animated abstract in video format (length 3 – 5 minutes) is accompanied by an English spoken or foreign language commentary. The animated abstract will be published online along with the published article.

The payment for an animated abstract will be US$ 1400 for English language, and US$ 1900 for Foreign language articles. Initially, an advance payment of US$ 500 of the total payment will be payable to the Publisher to start work on the Animated Abstract, US$ 900 (English language) or US$ 1400 (Foreign language) will be payable on completion of the Animated Abstract.

Authors who opt for the “Animated Abstract” option and also wish to have their article made available on an “Open Access Plus” basis will be entitled to a 50% discount only on the Animated Abstract fee and, in addition, pay the normal Open Access Plus fee.

Authors will be asked whether they wish to opt-in for this paid service, and if not, the article will be published as normal. Animated abstracts are available as open access (free viewing) for maximum visibility and awareness to your readers at anytime, anywhere. The animated abstracts are licensed under the terms of the Creative Commons Attribution – NonCommercial-NoDerivatives 4.0 International Public License (CC BY-NC-ND 4.0) https://creativecommons.org/licenses/by-nc-nd/4.0/.

One of our animated abstracts can be viewed below:

Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps

Journal Name: Current Medicinal Chemistry

Author(s): Hannah Y. Mahmood, Shirin Jamshidi, J. Mark Sutton, Khondaker M. Rahman.

 

 

 

Antimicrobial resistance represents a significant challenge to future healthcare provision.An acronym ESKAPEE has been derived from the names of the organisms recognised as the major threats although there are a number of other organisms, notably Neisseria gonorrhoeae, that have become equally challenging to treat in the clinic. These pathogens are characterised by the ability to rapidly develop and/or acquire resistance mechanisms in response to exposure to different antimicrobial agents. A key part of the armoury of these pathogens is a series of efflux pumps, which effectively exclude or reduce the intracellular concentration of a large number of antibiotics, making the pathogens significantly more resistant. These efflux pumps are the topic of considerable interest, both from the perspective of basic understanding of efflux pump function, and its role in drug resistance but also as targets for the development of novel adjunct therapies. The necessity to overcome antimicrobial resistance has encouraged investigations into the characterisation of resistance-modifying efflux pump inhibitors to block the mechanisms of drug extrusion, thereby restoring antibacterial susceptibility and returning existing antibiotics into the clinic. A greater understanding of drug recognition and transport by multidrug efflux pumps is needed to develop clinically useful inhibitors, given the breadth of molecules that can be effluxed by these systems. This review discusses different bacterial EPIs originating from both natural source and chemical synthesis and examines the challenges to designing successful EPIs that can be useful against multidrug resistant bacteria. To know more about our Animated Abstract, please visit: http://www.eurekaselect.com/video.html

Press Release | Bentham science’s latest book ‘Frontiers in Anti-Cancer Drug Discovery Volume 10’

 

This eBook is authored by Dr. Atta-ur-Rahman, published on June; this book is authored by Atta-ur-Rahman and M. Iqbal Choudhary; published on May 31, 2019. For Further Details, Please Visit : https://ebooks.benthamscience.com/book/9789811400711/

9789811400711-1.jpg

Frontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest advances in anti-cancer drug design and discovery. In each volume, eminent scientists contribute reviews relevant to all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field. The tenth volume of the series features chapters covering the following topics:

  • Challenges in the Management of Hepatoblastoma
  • The Emerging Role of Monocarboxylate Transporter-1 in Cancer
  • In-vitro Anti-Proliferative Assays and Techniques Used in Pre-Clinical Anti-Cancer Drug Discovery
  • Recent Advances in the Development of Mesoporous Anti-Cancer Drug Nanocarriers
  • Polyphenols and Cancer
  • Glioblastoma Multiforme
  • Cutting Edge Targeting Strategies Utilizing Nanotechnology in Breast Cancer Therapy
Read full press release to find out more at: https://www.eurekalert.org/pub_releases/2019-06/bsp-bsl062019.php

Become an Editorial Board Member (EBM) | Current Medicinal Chemistry

 

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Abstracted and Indexed in:

  • Science Citation Index®
  • Journal Citation Reports/Science Edition
  • InCites
  • Science Citation Index Expanded
  • Index to Scientific Reviews®
  • Biochemistry and Biophysics Citation Index®
  • Current Contents® – Life Sciences
  • Research Alert
  • BIOSIS
  • BIOSIS Previews
  • BIOSIS Reviews Reports and Meetings
  • Prous Science Integrity®
  • MEDLINE/PubMed/Index Medicus
  • Scopus
  • EMBASE/Excerpta Medica
  • Chemical Abstracts Service/SciFinder
  • ProQuest
  • ChemWeb
  • Google Scholar
  • BIOBASE
  • Reference Update
  • PubsHub
  • Index Copernicus
  • MediaFinder®-Standard Periodical Directory
  • Genamics JournalSeek
  • J-Gate
  • CNKI Scholar
  • Suweco CZ
  • TOC Premier
  • EBSCO
  • British Library
  • Ulrich’s Periodicals Directory
  • JournalTOCs

The Journal Current Medicinal Chemistry is interested in appointing active Editorial Board Member  on the Journal’s Board. If you are working in the mentioned field of the journal and are interested in becoming an Editorial Board Member, please send us your CV and a list of publications. If, however, the scope of the journal is not directly related to your field of interest, please feel free to recommend suitable colleagues for the said position and, if possible, send us their CV along with their list of publications. Mention in the subject line, the field of interest and send your CV at hermain@benthamscience.net and CC faizan@benthamscience.net

 

Wordpress.jpg

 

Become a Reviewer | Current Medicinal Chemistry

 

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth/mini reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Abstracted and Indexed in:

  • Science Citation Index®
  • Journal Citation Reports/Science Edition
  • InCites
  • Science Citation Index Expanded
  • Index to Scientific Reviews®
  • Biochemistry and Biophysics Citation Index®
  • Current Contents® – Life Sciences
  • Research Alert
  • BIOSIS
  • BIOSIS Previews
  • BIOSIS Reviews Reports and Meetings
  • Prous Science Integrity®
  • MEDLINE/PubMed/Index Medicus
  • Scopus
  • EMBASE/Excerpta Medica
  • Chemical Abstracts Service/SciFinder
  • ProQuest
  • ChemWeb
  • Google Scholar
  • BIOBASE
  • Reference Update
  • PubsHub
  • Index Copernicus
  • MediaFinder®-Standard Periodical Directory
  • Genamics JournalSeek
  • J-Gate
  • CNKI Scholar
  • Suweco CZ
  • TOC Premier
  • EBSCO
  • British Library
  • Ulrich’s Periodicals Directory
  • JournalTOCs

The Journal Current Medicinal Chemistry is interested in appointing active Reviewers on the Journal’s Board. If you are working in the mentioned field of the journal and are interested in becoming a Reviewer, please send us your CV and a list of publications. If, however, the scope of the journal is not directly related to your field of interest, please feel free to recommend suitable colleagues for the said position and, if possible, send us their CV along with their list of publications. Mention in the subject line, the field of interest and send your CV at hermain@benthamscience.net and at CC faizan@benthamscience.net

 

Wordpress - Reviewer.jpg

New Issue | Letters in Drug Design & Discovery (Volume: 16, Issue: 6)

 

lddd.jpg

 

Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of latest Internet technology for both submission and review of manuscripts. The online journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

 

Articles from the journal: Letters in Drug Design & Discovery; Volume: 16, Issue: 6

 

For details on the articles, please visit this link: http://www.eurekaselect.com/node/634/letters-in-drug-design-discovery/issue/16/2491/6/9079

AIMS & SCOPE | Letters in Drug Design & Discovery

AIMS & SCOPE

Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of latest Internet technology for both submission and review of manuscripts. The online journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery. To learn more about the journal, please visit: https://benthamscience.com/journals/letters-in-drug-design-and-discovery/

 

lddd-flyer.jpg

Become a Reviewer | Current Medicinal Chemistry 

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Abstracted and Indexed in:

  • Science Citation Index®
  • Journal Citation Reports/Science Edition
  • InCites
  • Science Citation Index Expanded
  • Index to Scientific Reviews®
  • Biochemistry and Biophysics Citation Index®
  • Current Contents® – Life Sciences
  • Research Alert
  • BIOSIS
  • BIOSIS Previews
  • BIOSIS Reviews Reports and Meetings
  • Prous Science Integrity®
  • MEDLINE/PubMed/Index Medicus
  • Scopus
  • EMBASE/Excerpta Medica
  • Chemical Abstracts Service/SciFinder
  • ProQuest
  • ChemWeb
  • Google Scholar
  • BIOBASE
  • Reference Update
  • PubsHub
  • Index Copernicus
  • MediaFinder®-Standard Periodical Directory
  • Genamics JournalSeek
  • J-Gate
  • CNKI Scholar
  • Suweco CZ
  • TOC Premier
  • EBSCO
  • British Library
  • Ulrich’s Periodicals Directory
  • JournalTOCs

The Journal “Current Medicinal Chemistry” is interested in appointing active Reviewers on the Journal’s Board. If you are working in the field mentioned and are interested in becoming an Reviewer, send your CV and a list of publications at the below mentioned email. If the scope of the journal is not directly related to your field of interest then please feel free to recommend suitable colleagues for the Reviewer of the journal and send us their CV and a list of publications, if possible.

Submit your CV at your earliest convenience at hermain@benthamscience.net and CC faizan@benthamscience.net, mentioning in the subject line your field of interest. The responsibilities of Reviewer will be discussed in detail further once the CV is received.

 

reviewer-banner-

 

Become an Editorial Board Member (EBM) | Current Medicinal Chemistry 

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Abstracted and Indexed in:

  • Science Citation Index®
  • Journal Citation Reports/Science Edition
  • InCites
  • Science Citation Index Expanded
  • Index to Scientific Reviews®
  • Biochemistry and Biophysics Citation Index®
  • Current Contents® – Life Sciences
  • Research Alert
  • BIOSIS
  • BIOSIS Previews
  • BIOSIS Reviews Reports and Meetings
  • Prous Science Integrity®
  • MEDLINE/PubMed/Index Medicus
  • Scopus
  • EMBASE/Excerpta Medica
  • Chemical Abstracts Service/SciFinder
  • ProQuest
  • ChemWeb
  • Google Scholar
  • BIOBASE
  • Reference Update
  • PubsHub
  • Index Copernicus
  • MediaFinder®-Standard Periodical Directory
  • Genamics JournalSeek
  • J-Gate
  • CNKI Scholar
  • Suweco CZ
  • TOC Premier
  • EBSCO
  • British Library
  • Ulrich’s Periodicals Directory
  • JournalTOCs

The Journal “Current Medicinal Chemistry” is interested in appointing active Editorial Board Members on the Journal’s Board. If you are working in the field mentioned and are interested in becoming an Editorial Board Member, send your CV and a list of publications at the below mentioned email. If the scope of the journal is not directly related to your field of interest then please feel free to recommend suitable colleagues for the Editorial Board Members of the journal and send us their CV CV and a list of publications, if possible.

Submit your CV at your earliest convenience at hermain@benthamscience.net and CC faizan@benthamscience.net, mentioning in the subject line your field of interest. The responsibilities of Editorial Board Members will be discussed in detail further once the CV is received.

 

banner

%d bloggers like this: